1198293-24-1 Usage
Uses
Used in Pharmaceutical Research:
7-BroMo-2,3-dihydro-1H-py... is used as a research compound for the development of new drugs targeting neurological disorders due to its unique structural properties and potential biological activity.
Used in Organic Synthesis:
7-BroMo-2,3-dihydro-1H-py... is used as a building block in organic synthesis for the creation of other biologically active molecules, contributing to the discovery of novel therapeutic agents.
Used in Chemical Research:
7-BroMo-2,3-dihydro-1H-py... is used as a subject of study in chemical research to understand the reactivity and behavior of heterocyclic compounds in various chemical reactions, providing insights into their potential applications and interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 1198293-24-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,8,2,9 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1198293-24:
(9*1)+(8*1)+(7*9)+(6*8)+(5*2)+(4*9)+(3*3)+(2*2)+(1*4)=191
191 % 10 = 1
So 1198293-24-1 is a valid CAS Registry Number.
1198293-24-1Relevant academic research and scientific papers
NOVEL PDE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION
-
Page/Page column 28, (2009/12/28)
The present invention relates to novel heterocyclic compounds of general formula (I), which are phosphodiesterase inhibitors (PDEs), in particular phosphodiesterase type 4 inhibitors, pharmaceutical compositions containing them, and processes for their preparation. These novel PDEs are useful in treating allergic and inflammatory diseases (such as asthma, COPD, allergic rhinitis, allergic conjunctivitis, respiratory distress syndrome, chronic bronchitis, nephritis, rheumatoid spondylitis, osteoarthritis, atopic dermatitis, eosinophilic granuloma, psoriasis, rheumatoid septic shock, ulcerative colitis, multiple sclerosis, chronic inflammation, Crohn's syndrome and central nervous system(CNS) disorders) and for inhibiting the production of Tumor Necrosis Factor(TNF-α).
